Kristin M. Leiferman,
MD
Languages Spoken: English
Kristin M. Leiferman, M.D. is a Dermatologist and Immunodermatologist with expertise in immune-mediated skin diseases, especially diagnosis and management of allergic skin diseases and diagnosis of autoimmune blistering diseases that affect skin and mucous membranes. She has board certification in Dermatology and Dermatological Immunology/Diagnostic and Laboratory Immunology.
Dr. Leiferman is Professor of Dermatology and Co-Director of the Immunodermatology Laboratory at the University of Utah, and has examined thousands of specimens for diagnosing autoimmune blistering diseases.
Although her specialized focus is on allergy-related inflammation, including mast cell- and eosinophil-associated diseases, and laboratory diagnosis, she is passionate about skin health in general, from acne to skin cancer, prevention and treatment.
Clinical Locations
801-581-2955
Dermatology, Area E
801-581-2955
Fax: (801) 585-2702
Board Certification and Academic Information
| Academic Departments | Dermatology
-
Professor Pathology - Adjunct Professor |
| Board Certification | American Board of Dermatology (Dermatology) American Board of Dermatology (Sub: Clin&Lab Derm Imm) National Board of Medical Examiners |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
5.0/ 5
Care provider's explanation of condition/problem
5.0/ 5
Care provider's effort to include me in decisions
5.0/ 5
Wait time at clinic
4.6/ 5
Care provider's concern for questions & worries
5.0/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Kristin M. Leiferman, M.D. is a Dermatologist and Immunodermatologist with expertise in immune-mediated skin diseases, especially diagnosis and management of allergic skin diseases and diagnosis of autoimmune blistering diseases that affect skin and mucous membranes. She has board certification in Dermatology and Dermatological Immunology/Diagnostic and Laboratory Immunology.
Dr. Leiferman is Professor of Dermatology and Co-Director of the Immunodermatology Laboratory at the University of Utah, and has examined thousands of specimens for diagnosing autoimmune blistering diseases.
Although her specialized focus is on allergy-related inflammation, including mast cell- and eosinophil-associated diseases, and laboratory diagnosis, she is passionate about skin health in general, from acne to skin cancer, prevention and treatment.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Dermatology
-
Professor Pathology - Adjunct Professor |
| Board Certification | American Board of Dermatology (Dermatology) American Board of Dermatology (Sub: Clin&Lab Derm Imm) National Board of Medical Examiners |
Research Interests
- Eosinophil-Associated Epithelial Disease
- Mastocytosis, Cutaneous
- Immunobullous Diseases
- Immunodermatology
Education History
| Residency | Mayo Clinic Dermatology Resident, 1983 |
| Professional Medical | Mayo Medical School Medicine M.D., 1978 |
| Undergraduate | University of Minnesota Biology B.S., 1973 |
Selected Publications - Journal Articles
Journal Article
- Leiferman KM, Snook JP, Khalighi MA, Kuechle MK, Zone JJ (2021). Diagnostics for Dermatologic Diseases with Autoantibodies. J Appl Lab Med, 7(1), 165-196.
- Saffari H, Peterson KA, Leiferman KM, Stabin MG, Krstyen JJ, Clayton FC, Pease LF 3rd, Yap JT, Hoffman JM, Gleich GJ (2019). Oral Administration of 99mTechnetium-Labeled Heparin in Eosinophilic Esophagitis. Mayo Clin Proc, 95(3), 449-458.
- Peterson KA, Gleich GJ, Limaye NS, Crispin H, Robson J, Fang J, Saffari H, Clayton F, Leiferman KM (2019). Eosinophil granule major basic protein 1 deposition in eosinophilic esophagitis correlates with symptoms independent of eosinophil counts. Dis Esophagus, 32(11).
- Mao X, Nagler AR, Farber SA, Choi EJ, Jackson LH, Leiferman KM, Ishii N, Hashimoto T, Amagai M, Zone JJ, Payne AS (2010). Autoimmunity to desmocollin 3 in pemphigus vulgaris. Am J Pathol, 177(6), 2724-30.
- Plager DA, Davis MD, Andrews AG, Coenen MJ, George TJ, Gleich GJ, Leiferman KM (2009). Eosinophil ribonucleases and their cutaneous lesion-forming activity. J Immunol, 183(6), 4013-20.
- Donaldson MR, Firth SD, Wimpee H, Leiferman KM, Zone JJ, Horsley W, OGorman MA, Jackson WD, Neuhausen SL, Hull CM, Book LS (2007). Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol, 5(5), 567-73.
- Plager DA, Weiss EA, Kephart GM, Mocharla RM, Matsumoto R, Checkel JL, Schwartz LB, Gleich GJ, Leiferman KM (2006). Identification of basophils by a mAb directed against pro-major basic protein 1. J Allergy Clin Immunol, 117(3), 626-34.
- Davis MD, Plager DA, George TJ, Weiss EA, Gleich GJ, Leiferman KM (2003). Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. J Allergy Clin Immunol, 112(5), 988-94.
- Trocme SD, Leiferman KM, George T, Bonini S, Foster CS, Smit EE, Sra SK, Grabowski LR, Dohlman CH (2003). Neutrophil and eosinophil participation in atopic and vernal keratoconjunctivitis. Curr Eye Res, 26(6), 319-25.
- Drage LA, Davis MD, De Castro F, Van Keulen V, Weiss EA, Gleich GJ, Leiferman KM (2002). Evidence for pathogenic involvementof eosinophils and neutrophilsin Churg-Strauss syndrome. J Am Acad Dermatol, 47(2), 209-16.
- Khan DA, Cody DT 2nd, George TJ, Gleich GJ, Leiferman KM (2000). Allergic fungal sinusitis: an immunohistologic analysis. J Allergy Clin Immunol, 106(6), 1096-101.
Review
- Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF, Hellmann A, Metzgeroth G, Leiferman KM, Arock M, Butterfield JH, Sperr WR, Sotlar K, Vandenberghe P, Haferlach T, Simon HU, Reiter A, Gleich GJ (2012). Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. [Review]. J Allergy Clin Immunol, 130(3), 607-612.e9.
- Gleich GJ, Leiferman KM (2009). The hypereosinophilic syndromes: current concepts and treatments. [Review]. Br J Haematol, 145(3), 271-85.